Suppr超能文献

中性粒细胞与淋巴细胞比值:慢性自发性荨麻疹患儿缓解的一个可能标志物。

Neutrophil-lymphocyte ratio: a possible marker of remission in children with chronic spontaneous urticaria.

作者信息

Karaman S, Turedi B

机构信息

Diyarbakır Children's Hospital, Department of Pediatric Immunology and Allergy, Diyarbakır, Turkey.

Diyarbakır Children's Hospital, Department of Pediatric Surgery, Diyarbakır, Turkey.

出版信息

Allergol Immunopathol (Madr). 2020 May-Jun;48(3):290-294. doi: 10.1016/j.aller.2019.11.007. Epub 2020 Apr 13.

Abstract

BACKGROUND

Chronic spontaneous urticaria (CSU) is a disease that seriously disturbs the quality of life of the patient. Currently there is no prognostic marker of the disease. Our aim in this study was to determine possible prognostic markers of CSU in children.

METHOD

All patients younger than 18 years of age who were followed by the Pediatric Immunology and Allergy Clinic of Diyarbakir Children's Hospital with a diagnosis of CSU between June 2017 and February 2019 were included in the study. Clinical and laboratory findings were compared between the symptomatic patient group and the patient group that remained in remission for at least three months without use of medication.

RESULTS

Of the 52 cases included in the study, 32 (61.5%) were male. Mean age at time of diagnosis was 9.4 ± 4.4 years. Twenty-four cases (46.2%) went into remission. Young age at the time of diagnosis and being in the initial months of the disease were found to be associated with good prognosis (p < 0.05). Among laboratory results, elevation in absolute neutrophil count and neutrophil/lymphocyte ratio (NLR) were found to be associated with poor prognosis (p < 0.05). NLR was positively correlated with disease duration (p < 0.05).

CONCLUSION

For childhood CSU, younger age and initial months of the disease are good prognostic indicators, while only neutrophil/lymphocyte count can be used as a remission marker.

摘要

背景

慢性自发性荨麻疹(CSU)是一种严重影响患者生活质量的疾病。目前尚无该疾病的预后标志物。本研究的目的是确定儿童CSU的可能预后标志物。

方法

纳入2017年6月至2019年2月期间在迪亚巴克尔儿童医院儿科免疫与过敏门诊就诊、诊断为CSU的所有18岁以下患者。对有症状的患者组和未使用药物至少缓解三个月的患者组的临床和实验室检查结果进行比较。

结果

本研究纳入的52例患者中,32例(61.5%)为男性。诊断时的平均年龄为9.4±4.4岁。24例(46.2%)进入缓解期。发现诊断时年龄较小以及处于疾病初期与良好预后相关(p<0.05)。在实验室检查结果中,绝对中性粒细胞计数和中性粒细胞/淋巴细胞比值(NLR)升高与预后不良相关(p<0.05)。NLR与疾病持续时间呈正相关(p<0.05)。

结论

对于儿童CSU,年龄较小和疾病初期是良好的预后指标,而只有中性粒细胞/淋巴细胞计数可作为缓解标志物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验